JSC
GILD icon

Jackson Square Capital’s Gilead Sciences GILD Stock Holding History

Jackson Square Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,785
Closed -$2.62M – 146
2026
Q1 		$2.62M Buy
18,785
+10,334
+122% +$1.45M 0.55% 46
2025
Q4 		$1.04M Buy
+8,451
New +$1.03M 0.21% 70
2025
Q3 		– Sell
-6,850
Closed -$760K – 152
2025
Q2 		$760K Sell
6,850
-1,161
-14% -$124K 0.17% 93
2025
Q1 		$898K Buy
8,011
+5,762
+256% +$595K 0.29% 66
2024
Q4 		$208K Buy
+2,249
New +$202K 0.05% 141
2024
Q2 		– Sell
-14,192
Closed -$1.04M – 138
2024
Q1 		$1.04M Sell
14,192
-137
-1% -$10.5K 0.27% 67
2023
Q4 		$1.16M Buy
14,329
+51
+0.4% +$3.97K 0.37% 55
2023
Q3 		$1.07M Buy
14,278
+638
+5% +$49.1K 0.43% 47
2023
Q2 		$1.05M Buy
13,640
+199
+1% +$15.9K 0.42% 53
2023
Q1 		$1.12M Buy
13,441
+185
+1% +$15.3K 0.5% 48
2022
Q4 		$1.14M Buy
+13,256
New +$1.05M 0.54% 50
2020
Q4 		– Sell
-860
Closed -$54K – 216
2020
Q3 		$54K Hold
860
– – 0.02% 174
2020
Q2 		$66K Hold
860
– – 0.03% 151
2020
Q1 		$64K Hold
860
– – 0.05% 111
2019
Q4 		$56K Buy
+860
New +$56K 0.03% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jackson Square Capital's GILD Position: Q2 2026 in Review

Jackson Square Capital sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 18,785 shares — an estimated $2.62M sold.

Jackson Square Capital first reported a position in GILD in Q4 2019 and held it in 15 quarters. The position peaked at $2.62M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jackson Square Capital reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Jackson Square Capital sold 18,785 Gilead Sciences shares in Q2 2026, an estimated $2.62M.
  • Jackson Square Capital first reported a position in Gilead Sciences in Q4 2019 and held it in 15 quarters.
  • Jackson Square Capital's Gilead Sciences position peaked at $2.62M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jackson Square Capital's 13F filing for Q2 2026, filed 21 Jul 2026.